Frank is a General Partner of GSA and a member of the firm's Investment Committee. He leads investments across all segments of private equity and offers particular expertise in healthcare venture capital and mid-sized European buyouts. Frank also pioneered GSA's investment strategy and portfolio in the traditional and renewable energy sectors. He is a member of a number of fund advisory boards.

Prior to joining GSA in 2001, Frank was a co-founder of Biocode Inc., a venture-backed biotech start up where he helped raise $15 million in venture capital over three rounds of financing. During his six-year tenure at Biocode, Frank played a number of executive roles, including 18 months as Managing Director, Asia, based in Singapore, and was a co-inventor on two patents. Previously, Frank spent three years in early-stage venture capital as an Associate at Innotage Management and as an Analyst in the healthcare group of Advent Venture Partners in London.

Education:
BA, Interdisciplinary Studies, University of Virginia
MBA, Harvard Business School (Baker Scholar)